Journal
NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-07667-z
Keywords
-
Categories
Funding
- Centre for Dengue Research, University of Sri Jayewardenapura, National Research Council, Sri Lanka [15-043]
- National Science Foundation, Sri Lanka [RPHS/2016/D-06]
- Medical Research Council (UK)
- National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC)
- MRC [MC_UU_12010/5, G0701693, G116/150, MC_U137881017, MC_UU_00008/5] Funding Source: UKRI
Ask authors/readers for more resources
The role of NS1-specific antibodies in the pathogenesis of dengue virus infection is poorly understood. Here we investigate the immunoglobulin responses of patients with dengue fever (DF) and dengue hemorrhagic fever (DHF) to NS1. Antibody responses to recombinant-NS1 are assessed in serum samples throughout illness of patients with acute secondary DENV1 and DENV2 infection by ELISA. NS1 antibody titres are significantly higher in patients with DHF compared to those with DF for both serotypes, during the critical phase of illness. Furthermore, during both acute secondary DENV1 and DENV2 infection, the antibody repertoire of DF and DHF patients is directed towards distinct regions of the NS1 protein. In addition, healthy individuals, with past non-severe dengue infection have a similar antibody repertoire as those with mild acute infection (DF). Therefore, antibodies that target specific NS1 epitopes could predict disease severity and be of potential benefit in aiding vaccine and treatment design.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available